In addition, introduction of cells with constitutively active AKT1 significantly rescued the inhibitory effect of RY-2f (Figure 5C), clearly indicating that the anti-cancer effect is dependent on suppression of the PI3K/AKT /mTOR pathway. The gene discussed is PIK3CA; the disease is cancer.